ClinicalTrials.Veeva

Menu

Prevalence of Faecal Bacteriophage in Patients With Digestive Symptoms (PREPHAGE)

C

Central Hospital, Nancy, France

Status

Not yet enrolling

Conditions

Gastroenteritis

Treatments

Other: bacteriophage detection

Study type

Observational

Funder types

Other

Identifiers

NCT06524791
2023-0323

Details and patient eligibility

About

Define the prevalence of fecal phage carriage in individuals with digestive symptoms (i) Determine the concentrations of infectious fecal phages in the stools of individuals with digestive symptoms (detection by culture)

(ii) Determine fecal phage genome concentrations in the stools of individuals with digestive symptoms (PCR detection)

(iii) Explore factors that could impact fecal phage carriage (patients with digestive symptoms vs. healthy individuals, immunocompromised patients vs. immunocompetent patients)

Enrollment

300 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age between 18 and 60.
  • Persons having developed gastrointestinal symptoms justifying microbiological stool testing at the time of hospitalization.
  • Person having received full information on the organization of the research and not having objected to the use of this data

Exclusion criteria

  • Persons covered by articles L. 1121-5, L. 1121-7 and L1121-8 of the French Public Health Code.
  • Pregnant or breast-feeding women,
  • Minors (not emancipated),
  • Adult subject to a legal protection measure (guardianship, curatorship, safeguard of justice),
  • Persons of full age who are unable to give their consent.
  • Persons deprived of their liberty by a judicial or administrative decision, persons under psychiatric care by virtue of articles L. 3212-1 and L. 3213-1.

Trial design

300 participants in 2 patient groups

immunocompetent
Description:
immunocompetent patients with digestive symptoms (n=150)
Treatment:
Other: bacteriophage detection
immunocompromised
Description:
immunocompromised patients with digestive symptoms (n=150)
Treatment:
Other: bacteriophage detection

Trial contacts and locations

1

Loading...

Central trial contact

Cédric Hartard

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems